{"url":"https://lda.senate.gov/api/v1/filings/5bad2b8a-bdce-4ac6-84dd-37dc0f20c8d0/","filing_uuid":"5bad2b8a-bdce-4ac6-84dd-37dc0f20c8d0","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2023,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/5bad2b8a-bdce-4ac6-84dd-37dc0f20c8d0/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"WILLIAM BURKE","dt_posted":"2023-07-23T15:46:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1455 Pennsylvania Ave Ste 400","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":315091,"url":"https://lda.senate.gov/api/v1/registrants/315091/","house_registrant_id":39394,"name":"RUBICON ADVISORS, LLC","description":"Lobbying firm","address_1":"1455 Pennsylvania Ave Ste 400","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"WILLIAM BURKE","contact_telephone":"+1 202-652-2290","dt_updated":"2026-07-20T10:39:00.156839-04:00"},"client":{"id":185329,"url":"https://lda.senate.gov/api/v1/clients/185329/","client_id":404,"name":"AVET PHARMACEUTICALS","general_description":"Sells Generic Pharmaceuticals","client_government_entity":false,"client_self_select":null,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-08-21"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33519,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"BURKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}